Fukunaga Y, Imagawa H, Kanemaru T, Kamada M
Equine Research Institute, Japan Racing Association, Shiba.
Vet Microbiol. 1993 Sep;36(3-4):379-83. doi: 10.1016/0378-1135(93)90104-f.
Virulent and avirulent strains of Bucyrus equine arteritis virus (EAV) were used to raise antiserum in horses. Serum neutralization (SN) tests were performed with and without the addition of guinea pig complement. The inclusion of ten percent guinea pig serum in the virus suspension was sufficient for optimal enhancement of SN titres at any immune stages after immunization. Immune serum prepared against avirulent virus reacted only with homologous virus and there was no complement enhancement. Immune sera raised against live or inactivated virulent virus neutralized both virulent and avirulent virus. The reaction with virulent virus demonstrated complement enhancement. There was also moderate potentiation in the presence of complement when serum raised against inactivated virulent virus reacted with avirulent virus.
使用强毒和无毒的比塞洛斯马动脉炎病毒(EAV)毒株在马体内制备抗血清。血清中和(SN)试验在添加和不添加豚鼠补体的情况下进行。在病毒悬液中加入10%的豚鼠血清足以在免疫后的任何免疫阶段最佳地提高SN滴度。针对无毒病毒制备的免疫血清仅与同源病毒反应,且无补体增强作用。针对活的或灭活的强毒病毒制备的免疫血清可中和强毒和无毒病毒。与强毒病毒的反应显示有补体增强作用。当针对灭活的强毒病毒制备的血清与无毒病毒反应时,在有补体存在的情况下也有适度的增强作用。